Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Schnurr

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Immunology and Cell Biology|April 22, 2009
Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvantEugene Maraskovsky, Max Schnurr, Nick S Wilson, et al.
The Journal of Experimental Medicine|July 18, 2020
Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19Lars M Koenig, Daniel F R Boehmer, Philipp Metzger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cellsMarc Dauer, Jan Herten, Christian Bauer, et al.
Cancer Research|April 17, 2002
Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cellsMax Schnurr, Christoph Scholz, Simon Rothenfusser, et al.
Immunology|August 28, 2003
Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulationMarc Dauer, Katrin Pohl, Bianca Obermaier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursorsMarc Dauer, Bianca Obermaier, Jan Herten, et al.
Frontiers in Immunology|February 7, 2018
Volcanic Ash Activates the NLRP3 Inflammasome in Murine and Human MacrophagesDavid E Damby, Claire J Horwell, Peter J Baxter, et al.
Journal of Immunological Methods|July 29, 2008
Combined use of toll-like receptor agonists and prostaglandin E(2) in the FastDC model: rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 productionMarc Dauer, Veronique Lam, Hannah Arnold, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2008
Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivoCornelia Wurzenberger, Viktor H Koelzer, Susanne Schreiber, et al.
Journal of Leukocyte Biology|June 14, 2006
IFN-alpha promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4Marc Dauer, Katharina Schad, Jana Junkmann, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Immunology and Cell Biology|April 22, 2009
Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvantEugene Maraskovsky, Max Schnurr, Nick S Wilson, et al.
The Journal of Experimental Medicine|July 18, 2020
Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19Lars M Koenig, Daniel F R Boehmer, Philipp Metzger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cellsMarc Dauer, Jan Herten, Christian Bauer, et al.
Cancer Research|April 17, 2002
Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cellsMax Schnurr, Christoph Scholz, Simon Rothenfusser, et al.
Immunology|August 28, 2003
Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulationMarc Dauer, Katrin Pohl, Bianca Obermaier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursorsMarc Dauer, Bianca Obermaier, Jan Herten, et al.
Frontiers in Immunology|February 7, 2018
Volcanic Ash Activates the NLRP3 Inflammasome in Murine and Human MacrophagesDavid E Damby, Claire J Horwell, Peter J Baxter, et al.
Journal of Immunological Methods|July 29, 2008
Combined use of toll-like receptor agonists and prostaglandin E(2) in the FastDC model: rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 productionMarc Dauer, Veronique Lam, Hannah Arnold, et al.
Cancer Immunology, Immunotherapy : CII|October 28, 2008
Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivoCornelia Wurzenberger, Viktor H Koelzer, Susanne Schreiber, et al.
Journal of Leukocyte Biology|June 14, 2006
IFN-alpha promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4Marc Dauer, Katharina Schad, Jana Junkmann, et al.
Pageof 7